Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:2 Issue:7 Number:580 ISSN#:2563-5476
ACE Report #4385
Ace Report Cover Metabolic Disorders

Aspirin reduces risk of recurrence in patients with unprovoked venous thromboembolism

How to Cite

OrthoEvidence. Aspirin reduces risk of recurrence in patients with unprovoked venous thromboembolism. ACE Report. 2013;2(7):580. Available from: https://myorthoevidene.com/AceReport/Report/4385

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Aspirin for preventing the recurrence of venous thromboembolism

N Engl J Med. 2012 May 24;366(21):1959-67. doi: 10.1056/NEJMoa1114238

Contributing Authors: C Becattini G Agnelli A Schenone S Eichinger E Bucherini M Silingardi M Bianchi M Moia W Ageno MR Vandelli E Grandone P Prandoni WARFASA Investigators

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Two weeks following the completion of treatment with vitamin K antagonists, 403 patients with a previous unprovoked venous thromboembolism (VTE) were randomised into two groups. Patients either received 100 mg aspirin or a placebo, once per day for 2 years, to measure the recurrence of VTE. Following assessments every 3 months in the first year and every 6 months in the second year, the results de...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.